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Abstract
A hydrogel based on chitosan, collagen, hydroxypropyl-c-cyclodextrin and polyethylene glycol was
developed and characterized. The incorporation of nano-hydroxyapatite and pre-encapsulated hy-
drophobic/hydrophilic model drugs diminished the porosity of hydrogel from 81.62 6 2.25% to
69.98 6 3.07%. Interactions between components of hydrogel, demonstrated by FTIR spectroscopy
and rheology, generated a network that was able to trap bioactive components and delay the burst
delivery. The thixotropic behavior of hydrogel provided adaptability to facilitate its implantation in
a minimally invasive way. Release profiles from microspheres included or not in hydrogel revealed
a two-phase behavior with a burst- and a controlled-release period. The same release rate for
microspheres included or not in the hydrogel in the controlled-release period demonstrated that
mass transfer process was controlled by internal diffusion. Effective diffusion coefficients, Deff, that
describe internal diffusion inside microspheres, and mass transfer coefficients, h, i.e. the contribu-
tion of hydrogel to mass transfer, were determined using ‘genetic algorithms’, obtaining values be-
tween 2.641015 and 6.671015 m2/s for Deff and 8.501010 to 3.04109 m/s for h. The proposed
model fits experimental data, obtaining an R2-value ranged between 95.41 and 98.87%. In vitro cul-
ture of mesenchymal stem cells in hydrogel showed no manifestations of intolerance or toxicity,
observing an intense proliferation of the cells after 7 days, being most of the scaffold surface occu-
pied by living cells.
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Introduction
Hydrogels are three-dimensional hydrophilic polymeric networks,
which are able to absorb and retain large quantities of water, sol-
vents or biological fluids in the free space of their structure without
being dissolved in the same media. They can be generated through
physical crosslinking by weak cohesive forces, like ionic or hydrogen
bonds and p–p or van der Waals interactions, or chemical crosslink-
ing by stable covalent forces that improve the mechanical properties
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of the hydrogel. However, the toxicity derived from the use of cross-
linking agents, like glutaraldehyde, and the possibility of irreversible
broken bonds that can fracture the structure, are some of the draw-
backs of the chemical crosslinking [1–3]. The high permeability and
porosity of hydrogels facilitates, not only integration in the majority
of tissues, but also incorporation by the cells, and their biocompati-
bility and biodegradation avoid surgery to remove polymer after
treatment [2, 3]. Moreover, their similarity to the extracellular ma-
trix or tissues, low interfacial tension between gel and solvents, and
minimal irritation after application due to their water content and
soft nature [2, 3] have made hydrogels the ideal candidates for bio-
medical and pharmaceutical applications, such as implants and
sutures, wound dressings, controlled drug delivery, diagnostic imag-
ing, medical and biological sensors or microfluidics [3, 4]. In this re-
gard, ‘in situ’ two-step forming injectable hydrogels have attracted
the attention of scientific community since they can be implanted
without surgery directly by injection in the treatment site, where the
crosslinker agent forms stable scaffolds. Rheology of this type of
hydrogels provides adaptability to the shape of the area to be
treated, an easy ‘in vivo’ implantation in a minimally invasive way
and capacity to incorporate bioactive substances and/or cells.
A long list of biodegradable natural or synthetic polymers has
been used to prepare hydrogels. Natural polymers include
polysaccharide-based polymers (chitosan, alginate, cellulose, dex-
tran, gellan or guar gum, cyclodextrins and hyaluronic acid) and
protein-based polymers (gelatin, collagen, albumin, fibrin or hepa-
rin). Although they are abundant in nature and can be part of bio-
logical events, such as signaling or cell adhesion, they do not have
good mechanical properties and tunable degradation by themselves
and can lead to possible immunogenic responses [4, 5]. In particular,
polysaccharide-based hydrogels offer interesting options to enclose
molecules since they can be easily formed by mild conditions meth-
ods, like ionic gelation or complexation in aqueous environments at
room temperature, avoiding the use of organic solvents and high
shear homogenization or ultrasonication. In fact, chitosan, a cat-
ionic natural linear polymer derived from chitin and composed of D-
glucosamine and N-acetyl-D-glucosamine units, gels by interaction
with polyanions, like the negatively charged and nontoxic tripoly-
phosphate (TPP) [6]. Chitosan-based hydrogels have been used as in-
jectable platforms in controlled drug delivery and tissue engineering
applications [5]. Moreover, chitosan can be mixed with the protein-
based polymer collagen since both solutions are miscible and chito-
san does not denature collagen [7]. The strategy of adding collagen
to hydrogel formulation brings advantages like enhanced mechani-
cal strength, biocompatibility and biodegradability, and a more effi-
cient cellular growth [4]. Although collagen can form gels by natural
means, the resulting mechanical strength is weak, being necessary
the use of crosslinking agents. For example, glutaraldehyde or form-
aldehyde have demonstrated effectiveness in creating crosslinking
structures in collagen but limit their application in biomedical sys-
tems because of their cytotoxicity [3, 8]. Another option to crosslink
collagen is the use of water-soluble carbodiimides, although they are
not usable when the enclosed bioactive substances are proteins be-
cause they react with them [3]. Riboflavin combined with
ultraviolet-A light has been widely used in clinic to reinforce the col-
lagen structure of the cornea in the treatment of keratoconus [9, 10].
Therefore, this seems to be a good strategy to induce crosslinking of
collagen and increase its mechanical strength without compromising
cell viability. Moreover, the addition of cyclodextrins, a cyclic oligo-
saccharide composed of six to eight glucopyranose units, can lead to
the formation of inclusion complexes with certain polymer regions.
The toxicity of these compounds decreases with increasing number
of glucopyranose units, thus, gamma cyclodextrins are less toxic
than alpha or beta ones [11]. Synthetic polymers, like poly(DL-lac-
tide-co-glycolide) (PLGA), poly(DL-lactide) (PLA), poly(vinyl alco-
hol) (PVA), poly(acrylic acid) (PAA), polyethylene glycol (PEG), can
enhance and control the mechanical strength and degradation rates
of hydrogels. Still, they do not provide the optimal environment for
cell inclusion and tissue regeneration, so, a combination of both
types of polymers, natural and synthetic, must be used for the bio-
medical application of hydrogels [5, 12, 13]. Moreover, the incorpo-
ration of inorganic components into the hydrogel structure, such as
hydroxyapatite (HAp) i.e. part of the bone matrix, have been used
in hard tissue repair to reinforce the mechanical properties of the hy-
drogel [14]. In this regard, nanosized HAp (nano-HAp) should be
used to promote their degradation by osteoblastic enzymes, like the
alkaline phosphatase, and form new tissue by osteoblasts, being this
size the optimum for enhanced cell adhesion and proliferation [14].
Bioactive substances can be released from hydrogels by either
degradation of polymer or diffusion through the pores of their struc-
ture, or by a combination of both. Release profiles in these systems
typically reveal a two-phase behavior, a burst step followed by a
slow controlled release period. Because of burst may cause high con-
centrations of bioactive substances in the application site and conse-
quently loss of these drugs, more complex systems are required to
reduce such burst profiles, maintaining the total delivery values in
longer periods.
In this work, an innovative hydrogel based on biocompatible
and biodegradable polymers, such as, chitosan, collagen, hydroxy-
propyl-c-cyclodextrin (HP-c-CD) and PEG, has been designed, de-
veloped and characterized in terms of porosity, rheology and mass
transfer studies. The hydrogel was injectable, adaptable to treatment
sites with diverse dimensions and shapes, easily crosslinked by
means of TPP and blue light and presented adequate characteristic
for good cell adhesion, viability and proliferation. Moreover, 17-b-
estradiol or rhodamine-B-isothiocyanate-dextran (RITC-dextran),
as low molecular weight hydrophobic or high molecular weight hy-
drophilic model drugs, respectively, were encapsulated in PLGA/
PLA microspheres and included in the hydrogel, together with the





RG504 (acid-terminated, lactide:glycolide 50:50,
Mw 38–54 kDa) and RG858S (ester-terminated, lactide:glycolide
85:15, Mw 190–240 kDa) and PLA Resomer
VR RG203-S (ester-termi-
nated, Mw 18–28 kDa) were acquired from Boehringer-Ingelheim
(Germany). HP-c-CD (CAVASOLV
R
W8 HP) was obtained from
Wacker (Germany). Ultrapure chitosan ProtasanTM UP-CL-213
(86% deacetylation, viscosity 150 mPas at 1 wt. % aqueous solu-
tion) and ultrapure alginate PronovaTM UP MVG were purchased
from NovaMatrix (Norway). Bovine collagen, type I, was purchased
from CellSystems Biotechnologie Vertrieb GmbH (Germany).
Calcium chloride dihydrate (Bioxtra, 99% pure), sodium citrate
tribasic dihydrate (ACS reagent, 99% pure), disodium hydrogen
phosphate (ACS reagent, 99% pure), sodium carbonate monohy-
drate (ACS reagent, 99.5% pure), hydrochloric acid (ACS reagent,
37 wt. % in H2O), 17b-estradiol, dichloromethane (puriss 99, 0%
pure), PVA (Mw 30–70 kDa, 87–90% hydrolyzed), riboflavin
(98% pure), PEG 400 (for synthesis), RITC-dextran (average Mw
70 kDa) and TPP (practical grade, 90–95% pure) were provided
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from Sigma Aldrich (St. Louis, MO, USA). All solutions were pre-
pared with ultrapure water (0.22 lS, 25C, Milli-Q, Millipore).
High glucose DMEM and penicillin/streptomycin were acquired to
HyClone (Utah, USA) and PAA laboratories (Pashing, Austria),
respectively. Fetal bovine serum (South America Origin) and L-gluta-
mine were provided from Biowest (France). Calcein-AM and p-
formaldehyde were purchased from Fluka Analytical (USA) and
Panreac (Spain), respectively.
Microspheres preparation
RITC-dextran-loaded PLGA microspheres were prepared, as previ-
ously described [15], by double emulsion solvent evaporation
method (water/oil/water). Briefly, a first emulsion was formed by
mixing (vortex) 200ml of a solution of 14.4 mg/ml of RITC-dextran
(2880mg) in 0.2% w/v PVA with 1 ml of DCM containing 150 mg
of PLGA [RG504: RG858S (4:1)]. Then, this first emulsion was
poured into 10 ml of 0.2% w/v PVA under vortex, forming the sec-
ond emulsion that was added over 100 ml of 0.1% w/v PVA under
magnetic stirring. This preparation was then left for 1 h under mild
agitation to evaporate the solvent. Microspheres were collected by
filtration, lyophilized and stored at 4C until required. Blank micro-
spheres were prepared with the same method but using as aqueous
phase 200ml of a solution of 0.2% w/v PVA without RITC-dextran.
17-b-Estradiol-loaded PLA/PLGA microspheres were prepared
by simple emulsion solvent evaporation method (oil/water). Briefly,
0.6 ml of an organic phase DCM: MeOH (83:17) containing 200 mg
of polymer PLA/PLGA [RG-203S: RG858S (4:1)] and 4 mg of 17-b-
estradiol were mixed by vortex with 4 ml of 1% w/v PVA to form
an emulsion that was poured into 96 ml of 0.16% w/v PVA under
magnetic stirring. Then, the formulation was left 1 h under mild agi-
tation to allow the evaporation of the solvent. Microspheres were
collected by filtration, lyophilized and stored at 4C until use. Blank
microspheres were synthetized using the same method but removing
17-b-estradiol from the organic phase.
Carbonated apatite nanoparticles preparation
(nano-hydroxyapatite)
Citrate-coated carbonated apatite nanoparticles were prepared by
the thermal decomplexing of metastable solution containing Ca2þ–
citrate complexes in the presence of phosphate and carbonate ions
at pH¼8.5 [16, 17]. Powders were synthesized as follows: 50 ml of
a solution (a) of composition 0.06 M Na2HPO4þ0.1 M Na2CO3
was poured into 50 ml of a solution (b) of composition 0.1 M
CaCl2þ0.2 M Na3(cit) at 4C. Then, pH was adjusted to 8.5 with
diluted HCl. The mixed solution was introduced into a bottle sealed
with a screw cap, immediately submerged in a water bath at 80C
and then moved to an oven with circulated forced air at the same
temperature. The experiments lasted 96 h. Upon completion, the
precipitates were washed with ultrapure water by six consecutive
cycles of centrifugation to remove unreacted species or salts.
Afterward they were freeze-dried overnight. Theoretical reaction
yielding carbonated apatite nanoparticles can be represented by:
5CaðcitÞ þ 3HPO4 þ ðx þ yÞ CO32 þ OH
! Ca5ðOHÞ1xðCO3ÞxðPO4Þ3yðCO3Þy þ 5cit3
þ 3Hþ þ xOH
Hydrogel preparation
A 10 mg/ml type I collagen solution in a cold solution of acetic acid
0.043 M, a 0.43 g/ml aqueous solution of HP-c-CD with riboflavin
(5 mg/ml) and a 20 mg/ml solution of chitosan in water were pre-
pared. In addition, pure PEG 400 (density: 1.128 g/ml) was used.
Hydrogel was prepared by mixing with vortex the enough quantity
of all the previous components to obtain the following final concen-
trations, 5.3 mg/ml of collagen, 33.8 mg/ml of HP-c-CD (0.4 mg/ml
of riboflavin), 5.3 mg/ml of chitosan and 148.4 mg/ml of PEG 400.
Afterward, this hydrogel was crosslinked with 25ml of 5% w/v TPP
sterile aqueous solution per 50ml of hydrogel under blue visible light
(468 nm, quartz-tungsten halogen Hilux UltraPlus, Benlioglu Dental
Inc.). In addition, hydrogels with microspheres and nano-HAp were
prepared by adding 14 mg of blank or 17-b-estradiol-loaded PLA/
PLGA microspheres, 5 mg of blank or RIBD-dextran-loaded PLGA
microspheres and 5 mg of nano-HAp per 50ml of hydrogel, simulat-
ing the therapeutic doses of 17-b-estradiol and osteogenic proteins,
such as BMP-2, in 50ml of hydrogel.
Characterization of microspheres, nano-HAp and
hydrogels
Size and morphology of microspheres were determined by laser dif-
fractometry (Mastersizer 2000, Malvern Instruments) and scanning
electron microscopy (SEM, Jeol JSM-6300), respectively.
Size and morphology of nano-HAp were performed by transmis-
sion electron microscopy (TEM) with a Carl Zeiss Libra 120. The
composition analysis of the carbonated apatite nanoparticles were
carried out by X-ray diffraction (XRD) and Fourier transform infra-
red (FTIR) spectroscopy. XRD data were collected by using a
Bruker D8 Advance Vario diffractometer with Bragg–Brentano par-
afocusing geometry. FTIR spectrum of the sample was recorded in
transmittance mode with a Perkin-Elmer Spectrum One FTIR spec-
trometer within the wavenumber range from 4000 to 400 cm1 at a
resolution of 4 cm1, using a pellet that was prepared by mixing
1 mg of sample with 100 mg of anhydrous KBr and then pressed
with a hydraulic pump into 13 mm diameter discs.
Porosity of hydrogels, with and without microspheres and nano-
HAp, was calculated from the true density (helium pycnometer,
Micromeritics AccuPyc 1330) and the apparent density of the
freeze-dried hydrogels prepared in a graduated cylindrical mold. To
avoid collapse processes during freeze-drying, the hydrogel was
maintained in a mold and quickly frozen with liquid nitrogen before
being exposed to a high-vacuum lyophilization process. The exis-
tence of true pores was verified by means of SEM.
Viscoelastic and thixotropic behaviors of hydrogel were obtained
with a Bohlin CVOD 100 rheometer at 37C by means of a Peltier
system, using cone-plate and parallel geometries with a diameter for
the fixed lower plate of 60 mm and a gap between the fixed and ro-
tating part of 1 mm. The evolution of viscosity with shear rate (from
0.071 to 30 s1) was acquired by cone-plate geometry (diameter of
cone 40 mm, angle 4). The evolution of elastic (G’) and viscous
moduli (G’’) with frequency (from 0.128 to 4.015 Hz) was acquired
by a parallel plate geometry (diameter of rotating upper plate
20 mm) at a constant shear stress of 0.2387 Pa. Note that for the vis-
coelastic characterization, the final crosslinking step with blue light
and 5% w/w TPP was not used and only blank microspheres were
used.
Analysis of the functional groups of the components of the hy-
drogel were determined by FTIR spectroscopy with a Bruker IFS 66/
S, in transmittance mode, within the wavenumber range from 4000
to 400 cm1 at a resolution of 4 cm1, using the attenuated total re-
flectance accessory that permit to examine samples in the solid state.
In vitro release profiles and encapsulation efficiencies of 17-b-es-
tradiol and RITC-dextran from microspheres and microspheres-
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loaded hydrogels were determined at 37C and 120 rpm (orbital agi-
tator) with a spectrophotometer (Ultrospec 3300 ‘pro’, Amersham
Biosciences) at 280 or 555 nm, respectively. Precisely, 26 mg of
17-b-estradiol-loaded PLA/PLGA microspheres (382mg), included
or not into 100ml of hydrogel were placed in a vessel with 4 ml of re-
lease medium. Simultaneously, 70 mg of RITC-dextran-loaded
PLGA microspheres (1071mg) included or not into 200ml of hydro-
gel were placed in a vessel with 2.5 ml of release medium. The re-
lease media consisted of 0.9% NaCl solution, which was mixed
with methanol in a ratio 60:40 to increase the solubility of the hy-
drophobic drug and then assess the sink condition, or ultrapure wa-
ter. Two methods of sampling were used, 500ml of media was
collected at different time points and then either returned to the ves-
sel (batch) or removed and replaced with fresh medium (semi-
continuous).
All the experiments performed to characterize the microspheres
and the hydrogel were performed in the SEGAI (Servicio General de
Apoyo a la Investigación) of the Universidad de La Laguna.
Cell culture
Cell isolation
All animal experiments were performed according to the EC direc-
tive 2010/63/EU on Care and Use of Animals in Experimental
Procedures. Furthermore, animal experiments were approved by the
committee for animal studies of Universidad de La Laguna.
Mesenchymal stem cells from femur bone marrow of 6 weeks-old
male Sprague Dawley rats (rMSC) were obtained by centrifugal iso-
lation as previously described by Dobson et al. [18]. Briefly, the cells
were resuspended in high glucose DMEM supplemented with 10%
fetal bovine serum, 1% penicillin/streptomycin and 2 mM
L-glutamine stable (complete culture medium, CCM). They were
seeded in flasks of 75 cm2 and incubated at 37C and 5% CO2.
Every 2–3 days the culture medium was changed until 80% of
confluence.
Culture of rMSC in the hydrogel and cell viability
Aliquots of 300ml of crosslinked collagen gel were placed into a
48-well plate. Then, 50 000 cells in 20ml of CCM were added to
each well and incubated at 37C and 5% CO2 for 1.5 h for cell ad-
hesion. The homogeneous cell distribution was confirmed by light
microscopy. Afterward, 500ml of CCM were added to each well,
and the plates were incubated during 7 days and the medium
changed every 3 days.
The seeded cell viability was tested with calcein-AM. After 1, 5 h
and 1, 3 and 7 days of culture, 3 wells of each time were washed (3
times) with Hank’s balanced salt solution (HBSS 1). Then 500ml
of 1mM calcein-AM in HBSS solution were added and incubated at
37C and 5% CO2 under soft agitation for 30 min. Then, calcein
was removed and cells were fixed with a solution of 3.7–4% p-form-
aldehyde buffered to pH¼7.0 during 30 min. After this, formalde-
hyde was removed, and the wells were washed 3 times with HBSS
1. Immediately after this, viable cells were visualized using a fluo-




The nanoparticles displayed plate-shape morphologies with average
length (L¼40.0 6 5.0 nm) and width (W¼9.5 6 1.2 nm) (TEM).
The XRD pattern of the sample is reported on Fig. 1A and corre-
spond to the apatite phase (PDF 01-1008), with peaks at
2h¼25.87 corresponding to the (002) plane, the triplet at 31.77,
32.19 and 32.90 (planes (211), (112) and (300)) respectively, the
reflections at 33.9 and 39.81 (planes (202) and 310)) and other
minor peaks in the 2h range from 40

to 55. The absence of octacal-
cium phosphate (OCP) is witnessed by the absence of the main re-
flection at 4.74, plane (100), (OCP, PDF 44-0778).
Figure 1B shows the FTIR spectrum of the sample in 400–
1800 cm1 region. The main band at 1000–1100 cm1 corresponds
to the asymmetric stretching mode of PO34 groups (t3 PO4). The
shoulder at 965 cm1 is ascribed to the symmetric stretching (t1
PO4) while less intense bands at 608 and 565 cm1 are due to the
(t4 PO4) bending mode of PO
3
4 groups [17, 19]. The presence of
carbonate (CO23 ) bands is attested by vibrational signatures due to
the t3CO3 mode, with maxima around 1415 and 1473 cm1, and
the t2 CO3 mode with a peak around 873 cm
1. Detailed analysis of
the t2CO3 region shows the signals at 879 and 872 cm1 corre-
sponding to A-type and B-type carbonate substitutions, with carbon-
ate ions replacing respectively OH and PO34
 lattice ions. Beside
apatitic vibrational contributions, a band at 1590 cm1 is also no-
ticed on all samples, which can be ascribed to the antisymmetric
stretching frequencies of the carboxylate groups of the citrate. Bands
at 2930 cm1 (not shown) and 840 cm1 (shoulder) are assign-
able to tCH2 and dCOO modes of the citrate ions [20], respectively.
Figure 1. (A) XRD pattern of carbonated apatite prepared by thermal decomplex-
ing of Ca/citrate/phosphate/carbonated solutions at pH¼8.5 at 80C. (B) FTIR
spectrum in transmittance mode of carbonated apatite prepared by thermal
decomplexing of Ca/citrate/phosphate/carbonated solutions at pH¼8.5 at 80C
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The presence of carbonate substituting –OH and PO34
 lattice
ions in the crystal structure as well as of a citrate layer coating the
surface of the nano-HAp crystals is also a characteristic feature of
the bone apatite. In bone, the apatite component is poorly crystalline
and also displays a plate-like morphology and is doped with carbon-
ate [21]. Recently, Hu et al. [22] have revealed that citrate, which
accounts for about 5.5 wt % of total organic matrix of bone, is
found strongly bound to the surface of the apatite nanoparticles.
The use of carbonate and citrate in the mother solutions is thus, a
straightforward nature inspired strategy to prepare bonelike apatites
to be used in combination with the new hydrogels for the tissue
regeneration.
Microspheres and collagen based-hydrogel
characteristics
The mean diameters in volume of the RITC-dextran-loaded PLGA
microspheres and b-estradiol-loaded PLA/PLGA microspheres were
99.70 6 5.00mm and 119.14 6 0.25mm, respectively. Both PLGA
and PLA/PLGA microparticles were generated using PVA which is
adsorbed in the surface of the particle and protect them from ag-
glomeration. Shakesheff et al. [23] indicated that part of PVA mole-
cules remain in the surface of the particles after consecutive washing
and cannot be removed since PVA forms a stable network with
PLGA. Figure 2A shows a SEM image of the generated PLGA micro-
spheres. The encapsulation efficiency of RITC-dextran and b-estra-
diol in the microspheres was 80.1 6 7.4% and 74.8 6 5.2%,
respectively. The high porosity of dry hydrogel, 81.62 6 2.25%, was
decreased up to 69.98 6 3.07% when microspheres and nano-HAp
were incorporated. Figure 2B shows a SEM image of the porous in-
ternal structure of the hydrogel after the incorporation of
microspheres.
PLGA and PLA/PLGA microspheres were generated without the
use of a porogen to avoid a rapid release of the model drugs. Oh
et al. [24] showed a decrease in encapsulation efficiency and a large
increase in the release rate of budesonide when ammonium bicar-
bonate (porogen) was included to generate PLGA microspheres. As
can be seen in the SEM image (Fig. 2A), the surface of microspheres
is solid and flat and no pores can be seen. Zhang et al. [25] reported
the synthesis of porous and non-porous PLGA microspheres by the
simple emulsion solvent evaporation method. In the absence of a
porogen, no pores were found in the resultant particles that had a
smooth surface; however, by using 2-methylpentane in the oil phase
as porogen, porous particles were generated. In the case of the tech-
nique of double emulsion solvent evaporation, several authors have
demonstrated the generation of porous PLGA microspheres by the
addition of ammonium bicarbonate [24, 26] or phosphate buffered
saline [27] in the first aqueous phase. In the absence of a porogen,
these authors did not found pores in the particles that showed a
smooth surface.
In the other hand, citrate-coated carbonated apatite nanopar-
ticles prepared by thermal decomplexing are non-porous and tend to
aggregate with time in mesoporous materials with a mean pore di-
ameter in the range between 100 and 200 Å [16].
The inclusion of non-porous microparticles and mesoporous
nano-HAp to the highly porous hydrogel will lead to a reduction in
their porosity. In fact, Wang et al. [26] showed the reduction of po-
rosity of sintered scaffolds by the inclusion of non-porous PLGA
microspheres (from 87.50 6 5.23% for scaffolds including porous
particles generated with a 1:10 porogen–polymer ratio to
43.2 6 9.39% for scaffolds including non-porous particles).
Viscoelastic behavior and interactions of compounds
on hydrogel
The incorporation of cyclodextrin, chitosan and PEG to the initial
collagen solution (10 mg/ml) (COL) did not add additional viscosity,
but generated consecutive dilutions as can be seen in Fig. 3, where
viscosity versus shear rate at 37C is represented. As expected, the
incorporation of microspheres and nano-hydroxyapatite produced
an increase in the viscosity values (Fig. 3, top right box).
Collagen, as many other polymers with long chains, has a non-
Newtonian pseudoplastic behavior, i.e. viscosity decreases as the
shear rate increases, being this process reversible when the stress is
removed. In particular, collagen solutions have thixotropic proper-
ties, taking some time to recover the initial viscosity values after
stress have been removed since the rearrangement of its structure is
a time-dependent process. In Fig. 3, the values of viscosity after the
application (forward curve) and removal (backward curve) of stress
did not match, mainly for the collagen solution (COL) and the com-
plete gel with spheres (COLþCDþCSþPEGþ spheres). The for-
ward and backward curves did not overlap, being the area between
both (or hysteresis loop) an indication of the magnitude of the thixo-
tropic behavior that permit the implantation of hydrogel in a mini-
mally invasive way and facilitate the adaptation to the shape of the
area to be treated, before being crosslinked ‘in-situ’ by means of
blue light and TPP.
The different interactions between the components of the hydro-
gel: collagen, cyclodextrin, chitosan and PEG, generate a gel net-
work i.e. able to trap the bioactive components, i.e. the pre-
encapsulated bioactive substances and nano-hydroxyapatite.
Collagen is a protein with a special and atypical combination of
amino acids, being glycine (Gly), proline (Pro) and hydroxyproline
(Hyp) the most repeated units that are responsible of the
Figure 2. (A) SEM image of lyophilized PLGA microspheres. (B) SEM image showing the internal structure of hydrogel
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triple-helical structure. Glycine, the dominant unit in collagen, facil-
itates the formation and stabilization of collagen structure by inter-
nal hydrogen bonding. This amino acid can be mostly part of the
sequences, Gly–Pro–X or Gly–X–Hyp, where X can be any other
amino acid with different functional groups, like carboxyl and
amino groups, in the outside part of the helix that are available for
reaction with other molecules [28, 29]. At the very end of both sides
of collagen molecules, there are terminal carboxyl and amino groups
that are not incorporated in the triple-helix and are part of two non-
helical domains (telopeptides) that are available for reaction with
other molecules [30]. The existence of hydrophobic residues within
the telopeptides region may allow their incorporation to the hydro-
phobic cavities of cyclodextrins, compromising the crosslinking pro-
cess in collagen and the subsequent fibrillogenesis and aggregation
processes [30]. In fact, cyclodextrin is a fundamental component in
the hydrogel by allowing the incorporation of hydrophobic com-
pounds, like the b-estradiol, directly in the gel without the need to
pre-encapsulate them in spheres. Moreover, cyclodextrin can rein-
force the collagen matrix by means of hydrogen bonds between the
multiple hydroxyl groups of cyclodextrin and the terminal and/or
side hydroxyl, amino, amide or carboxyl groups of collagen.
Figure 4A and B represents the variation of viscosity with the shear
rate and the elastic and viscous modulus with the frequency, respec-
tively, for a collagen solution (COL) and a mixture of collagen and
cyclodextrin (COLþCD). These figures demonstrated the above-
mentioned interactions between collagen and cyclodextrin. In this
regard, the incorporation of cyclodextrin to the collagen solution
increases the viscosity values (Fig. 4A) and the solid behavior of col-
lagen (both modulus increase, although the elastic to a greater ex-
tent, staying above in both cases) (Fig. 4B). Note that the same mass
ratio of the complete gel and the same collagen concentration was
maintained to avoid the dilution effect that was commented above
(Fig. 3).
The existence of hydrogen bonds between cyclodextrin and col-
lagen is observed in Fig. 5A, from the comparison of the fingerprint
region of the FT-IR spectra (from 1700 to 500 cm1) of collagen so-
lution and collagen/cyclodextrin mixture. The collagen spectra
shows the typical bands at 1627 cm1 (amide I: C¼O stretching)
and 1546 cm1 (amide II: N–H deformation and C–N stretching).
The incorporation of cyclodextrin to collagen produces a shift in the
amide I band to higher wave numbers (1658 cm1) and a great
decrease in the intensity of the amide II band (1546 cm1) in com-
parison with the amide I band that may suggest the formation of
new hydrogen bonds between peptide carbonyl groups in collagen
and hydroxyl groups in cyclodextrin. Note that the amide II band is
not present in the cyclodextrin spectra. The appearance of the band
at 1014 cm1 is due to the C–O vibrations because of the contribu-
tion of ether and hydroxyl groups of cyclodextrin molecules to the
mixture as can be seen in the cyclodextrin spectra of Fig. 5A.
Chitosan was added to the collagen–cyclodextrin mixture to
harden the hydrogel by crosslinking with TPP. Hydroxyl and amino
groups in chitosan are able to form hydrogen bonds with side groups
or carboxyl and amino end groups of collagen. Ionic interactions be-
tween the positively charged amino groups in chitosan and the nega-
tively charged carboxyl end groups in the telopeptide areas of
collagen are also possible [31]. Because of these interactions, chito-
san may be rolled around triple-helix of collagen, forming a complex
with an increased viscosity compared to the collagen–cyclodextrin
mixture. This behavior can be seen in the evolution of viscosity with
shear rate of collagen–cyclodextrin (COLþCD) and collagen–cyclo-
dextrin–chitosan (COLþCDþCS) mixtures (Fig. 4C). Moreover, the
incorporation of chitosan (COLþCDþCS) increase the elastic be-
havior of the collagen–cyclodextrin mixture (COLþCD) since the
difference between elastic and viscous modulus becomes bigger
(Fig. 4D). Note that the comparison between COLþCD and
COLþCDþCS was performed at the same conditions as Fig. 4A
and B.
The incorporation of chitosan to the collagen/cyclodextrin mix-
ture did not produce major changes in the fingerprint region of the
IR-spectra (Fig. 5B), showing the amide I band at 1658 cm1, the
amide II band of much lower intensity at 1546 cm1 and the C–O
band at 1014 cm1. This absence of changes in the IR-spectra indi-
cates the predominance of the ionic interactions between the cat-
ionic amino groups in chitosan and the anionic carboxylic end
groups in collagen against the hydrogen bonds between both
molecules.
Chitosan spectra in the fingerprint region (Fig. 5B) showed
mainly the amide I band at 1623 cm1 and the C–O stretching at
1050 cm1. This spectra also shows a band at 1515 cm1 that may
be due to the N–H bending of primary amines, since its greater in-
tensity with respect to the amide I band do not match with the amide
II band, which is not present in this spectra.
Figure 3. Variation of viscosity of collagen solution (10 mg/ml), before (COL) and after cyclodextrin (COLþCD), chitosan (COLþCDþCS) and PEG
(COLþCDþCSþPEG) incorporation, with shear rate at 37C. The upper box shows the viscosity versus shear rate of the complete gel, before (COLþCDþCSþPEG)
and after the incorporation of microspheres and nano-hydroxyapatite (COLþCDþCSþPEGþ spheres)
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The last component to be incorporated to hydrogel was PEG
that may produce the molecular crowding of collagen, forming
aligned fibrils. However, minor reversible interactions between col-
lagen and PEG by hydrogen bonding and ionic interactions may be
also possible [32, 33]. These facts may be supported by the increase
on viscosity in all the range of shear rate (Fig. 4E), when PEG is in-
cluded to the collagen–cyclodextrin–chitosan mixture. At low fre-
quencies, the big difference between the elastic and viscous modulus
of the collagen–cyclodextrin–chitosan mixture is decreased when
the PEG is incorporated, as shown in Fig. 4F. This behavior may be
caused by an approach to a Newtonian behavior because of the
great dilution of the final mixture, but, despite this, the hydrogel
remains elastic in the complete gel since the elastic module is above
the viscous module in all the frequency range. Note that comparison
between COLþCDþCS and COLþCDþCSþPEG were generated at
the same conditions as Fig. 4A and B. Although it is well known the
formation of inclusion complexes (polyrotaxanes) between alpha-
cyclodextrin and PEG [34, 35], the utilization of beta or gamma cy-
clodextrin as an alternative of alpha-cyclodextrin avoid the forma-
tion of polyrotaxane structures [36].
PEG 400 IR-spectra in the fingerprint region (Fig. 5C) shows the
C–H bands at 1457 and 1350 cm1, the C–O bands corresponding
to alcohol at 1292 and 1245 cm1, and the C–O–C of ether at
1099 cm1. The incorporation of PEG 400 to the hydrogel did not
alter the previously commented IR-spectra of collagen/cyclodextrin/
chitosan mixture, beyond the superimposition of both spectra. Only
Figure 4. Evolution of the viscoelastic behavior of collagen with the incorporation of cyclodextrin, chitosan and PEG. Variation of (A) viscosity with shear rate and
(B) elastic and viscous moduli with frequency in collagen (COL) versus a mixture of collagen and cyclodextrin (COLþCD) with a mass ratio equal to that in the final
gel, maintaining the collagen concentration in both samples (COL) and (COLþCD). Variation of (C) viscosity with shear rate and (D) elastic and viscous moduli
with frequency in collagen–cyclodextrin mixture (COLþCD) versus a collagen–cyclodextrin–chitosan mixture (COLþCDþCS) with a mass ratio equal to that in the
final gel, maintaining the collagen and cyclodextrin concentration in both samples (COLþCD) and (COLþCDþCS). Variation of (E) viscosity with shear rate and (F)
elastic and viscous moduli with frequency in collagen–cyclodextrin–chitosan mixture (COLþCDþCS) versus the complete gel (COLþCDþCSþPEG) with a mass
ratio equal to that in the final gel, maintaining the collagen, cyclodextrin and chitosan concentrations in both samples (COLþCDþCS) and (COLþCDþCSþPEG)
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a small increase in the difference between the intensities of the amide
I and amide II peaks (Fig. 5C) can be observed. This small change
may indicate a higher probability of occurrence of hydrogen bind-
ings and ionic interactions between collagen and PEG over the mo-
lecular crowding of collagen.
In vitro release profiles
In vitro release profiles of b-estradiol (Fig. 6) or RITC-dextran
(Fig. 7) from the microsphere-loaded hydrogel reveal a two-phase
behavior with a burst and a controlled release period. By comparing
these results with the respective profiles of microspheres, it is
Figure 5. FT-IR spectra in transmittance mode for (A) collagen, cyclodextrin and the mixture of both; (B) chitosan, collagen/cyclodextrin and collagen/cyclodex-
trin/chitosan mixtures; (C) PEG, collagen/cyclodextrin/chitosan and collagen/cyclodextrin/chitosan/PEG mixtures
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possible to conclude that burst release was reduced (see enlargement
of Fig. 6 or 7) because of the different interactions between the com-
ponents of the hydrogel previously mentioned and the crosslinking
process that entrap the bioactive substances. Burst release for b-es-
tradiol is accentuated during the first 24 h, while for RITC-dextran
is moderate the first 2–3 days, being the damping effect of the hydro-
gel much more visible in the case of the latter. The controlled release
period is produced the following 15 days or 3 weeks for b-estradiol
or RITC-dextran, respectively. The fact that this period occurs at
the same rate for the microspheres included or not in the hydrogel
may indicate that the release process is mainly controlled by internal
diffusion within microspheres. However, depending on the sampling
method, the final released fraction varies. When media is returned
after the measurement (Fig. 6B or 7B), the drug is accumulated con-
tinuously and the total drug released before the process stops will be
less than in the case of removing the sample after the measurement
(Fig. 6A or 7A). This is because in the latter case, the media is
renewed continuously and the concentration gradient between the
spheres and the media is increased each sampling time, which forces
the remaining drug to be released from the spheres until the concen-
tration inside them is at equilibrium with the media.
Experiments were carried out under sink conditions for both, hy-
drophobic and hydrophilic model drugs. Thus, b-estradiol was al-
most completely released from the spheres, i.e. 97 or 92% for the
semi-continuous or batch sampling methods, respectively (Fig. 6),
being able to assure that there was not crystallization inside the par-
ticles. However, not all the RITC-dextran molecules diffuse out and
the final released fraction was in the range between 29 and 47% for
all the experiments with this molecule (Fig. 7). These data are in ac-
cordance with the literature [37–39] and may be due to electrostatic
interactions between the negatively charged deprotonated carboxyl
groups of PLGA and the positively charged amine groups of rhoda-
mine from the RITC-dextran at pH values between 6 and 7 [40].
The complete release of this model drug can be achieved at acidic
pH values of 4–5 [40]. Note that the slower release rate of RITC-
dextran with respect to the data from literature is due to the high
molecular weight of dextran.
Mass transfer studies for hydrophobic and hydrophilic
drugs
The mass transfer process that occurs from polymeric microspheres,
as isolated systems or included in porous hydrogels, to the media in
body cavities with low clearance rates was simulated using two
model compounds, 17-b-estradiol and RITC-dextran, which mimic
low molecular weight hydrophobic and high molecular weight hy-
drophilic drugs, respectively.
Some systems based on natural polymers, like alginate or chito-
san, with short release times [41–43] behave as concentrated sys-
tems, i.e. uniform drug concentration within microspheres. Then,
diffusional resistance inside the microspheres is negligible compared
to the liquid boundary layer resistance i.e. the rate-limiting step, be-
ing able to describe the simplified release process by means of the
mass transfer coefficient, h [41, 42]. However, based on the experi-
mental in vitro profiles mentioned above, a distributed system must
be assumed, where the concentration gradient inside the micro-
spheres is rate limiting. Thus, the release process is mainly described
by means of the diffusion process inside the spheres and therefore by
the effective diffusion coefficient, Deff [44, 45].
Diffusion process from the spherical microparticles is governed
by Fick’s second law of diffusion in radial coordinates [44], accord-











for 0 < r < R; (1)
where C is the concentration of the drug, Deff is the effective diffu-
sion coefficient, t is the time, r is the radial coordinate and R is the
radius of the microparticles.
Equation (1) is solved with the surface boundary condition of no
accumulation described by Equation (2), which assumes that the
mass flow rate of the drug i.e. released to the media is equal to the






¼ h CS;sf  C0;1
 
for r ¼ R; (2)
where CS,sf is the drug concentration inside the spheres, but in the
surface; C0,1 is the drug concentration in equilibrium with the liq-
uid; Deff is the effective diffusion coefficient; r is the radial coordi-
nate; R is the radius of the microparticles and h is the mass transfer
coefficient in the boundary layer.
Resolution of Equation (1) with Equation (2) for a spherical ge-
ometry, considering a homogeneous distribution of the drug inside
the spheres at the beginning of the process, i.e. C(r) = C0 at t¼0, for
0< r<R (monolithic system), leads to Equation (3). This expression
Figure 6. In vitro release profile of b-estradiol from microspheres and microspheres-loaded hydrogel. In the upper right part of the figure is shown a magnifica-
tion of the first hours. (A) Semi-continuous sampling method; (B) batch sampling method
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permits the calculation of the fraction of the cumulative amount of
drug leaving the microspheres as a function of time [44, 45]. Note
that, C0 is the initial drug concentration inside the spheres, and per-
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where Mt and M1 are the total mass of drug released to the media
at time t and at the final of the process, respectively. M1 can be
obtained from the concentration of the drug inside the spheres at the
beginning of the process (t¼0) i.e. the value obtained by dissolution
of the spheres. The bns are the infinite roots (eigenvalues) of the
Equation (4):
bncotbn þ L 1 ¼ 0: (4)
L is the dimensionless mass transfer Biot number, described by
the Equation (5):
L ¼ h R
Deff
: (5)
For L below 0.01, the drug concentration within microspheres is
uniform, so the liquid boundary layer surrounding the spheres is
rate limiting and the spheres behaves as a concentrated system;
while for L above 10 the spheres acts as a distributed system, being
the resistance inside the polymer matrix of the spheres rate limiting.
For large values of L, the roots of Equation (4) are multiple of
the number pi and Equation (3) can be simplified in Equation (6) i.e.















Since microspheres in all cases are assumed as distributed sys-
tems, they must contribute in the same way to the global mass
transport process, whether or not they are included in the hydro-
gel. Thus, the latter can be considered as part of the boundary
layer between the spheres and the media. Equations (3–6) de-
scribe the complete mass transfer process, permitting to deter-
mine not only the effective diffusion coefficient in the polymer
matrix of the spheres, Deff, but also the mass transfer coefficient
in the boundary layer, h, to which the hydrogel contributes to a
greater extent.
Table 1 shows, for each sampling method, batch and semi-
continuous, the values of Deff that describe the internal diffusion of
17-b-estradiol and RITC-dextran inside microspheres and are in the
range of 2.641015 to 6.671015 m2/s. The contribution of hydro-
gel to the mass transfer process throughout the values of h, which
are in the range of 8.501010 to 3.04109 m2/s, are also shown in
Table 1. The behavior of both model drugs was similar in the system
regardless of the sampling method and no tendency was detected.
To obtain Deff and h, deviations between experimental released
fractions, M/M1, from microspheres included or not in hydrogels
and the predicted M/M1 according to Equations (3–6) were mini-
mized. This was made for each model drug and sampling method
with ‘genetic algorithms’, already implemented in ‘R software’ (R
Foundation for Statistical Computing, version 3.5.1., 2018, Vienna)
[46, 47], because of the ill-conditioned nature of diffusion equation.
The ‘residual sum of squares (RSS)’ values obtained were between
4.44104 and 2.27103 and the R2-values were ranged between
95.41 and 98.87%. The mathematical form of diffusion models is
an infinite series of terms itself nonlinear, making difficult the use of
the classical methods to fit nonlinear models. The RSS allows identi-
fying two common problems: multiple minima and strong nonlinear
profiles, which can result in a relative minimum, not the absolute
one. Note that predicted M/M1 was obtained using Equation (6) for
microspheres and Equations (3–5) for microspheres included in
hydrogels. The value of Deff was the same for microspheres, whether
they were included or not in the hydrogel, for each condition. The
hydrogel contributed to the mass transfer process with h, as part of
the boundary layer. The location of the predicted Deff and h within
the RSS level curves, obtained for a great variety of values of both
coefficients (Fig. 8), and the comparison (Fig. 9) of the experimental
released fractions, M/M1, (points) versus the simulated ones (lines)
demonstrate that the proposed model fits the experimental data for
both model drugs.
In vitro cell culture in hydrogels
The hydrogel presented adequate characteristics for a good cell ad-
hesion, viability and proliferation. The green fluorescent intensity
produced by the living cells was increased over the time (Fig. 10). At
1.5 h a few cells were observed on the surface of the scaffold. The
cell proliferation increased and after 7 days, most of the scaffold was
occupied by living cells.
Figure 7. In vitro and in vivo release profiles of RITC-dextran from microspheres and microspheres-loaded hydrogel. (A) Semi-continuous sampling method;
(B) batch sampling method
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Conclusions
An innovative thixotropic hydrogel based on chitosan, collagen,
HP-c-CD and PEG has been developed. In order to target its use in
bone regeneration, the hydrogel incorporated nano-hydroxyapatite
and microspheres loaded with hydrophobic or hydrophilic model
drugs (17-b-estradiol or RITC-dextran) that slightly diminished the
porosity of hydrogel to 69.98 6 3.07%.
The changes in the FT-IR spectra, the increase of viscosity and the
intensification of the solid behavior of collagen with the incorporation
of cyclodextrin suggested the incorporation of the residues of the telo-
peptide region of collagen inside the cavities of cyclodextrins and the
formation of new hydrogen bonds between both molecules. In a similar
way, the rheological parameters indicated the formation of hydrogen
bonds between chitosan and collagen; however, the FTIR spectroscopy
suggested the predominance of ionic interactions over the hydrogen
bonds between both molecules. The increase on viscosity, the mainte-
nance of the elastic behavior and the lack of variation in FT-IR spectra
when PEG was incorporated to the rest of components, suggested the
existence of ionic interactions between collagen and PEG. The interac-
tions between components together with the rheological behavior of hy-
drogel explain the formation of a gel network that allows to trap the
bioactive components and facilitate the adaptation and injection of the
hydrogel to diverse treatment sites.
In vitro release profiles of pre-encapsulated model drugs showed
a two-phase behavior with a burst release period that was damped
by hydrogel and a controlled release period with a similar rate
whether they are included or not in hydrogel, which indicated a
mass transfer process controlled by internal diffusion within micro-
spheres. Thus, a distributed system was assumed to model mass
transfer process of drugs from polymeric microspheres, as isolated
systems or included in porous hydrogels, to the media in body cavi-
ties with low clearance rates. The calculated effective diffusion coef-
ficients, Deff, that describe the internal diffusion of the model drugs
inside the microspheres, and the mass transfer coefficients, h, i.e. the
contribution of hydrogel to the mass transfer process, as part of the
boundary layer, did not show any tendency regardless of the sam-
pling method or the model drug used.
The in vitro culture of rMSC in hydrogel showed no signs of in-
tolerance or toxicity, observing an intense proliferation of the cells
after 7 days, being most of the scaffold surface occupied by living
cells.
Since mass transfer process is controlled by the internal diffusion
within microspheres, in order to obtain an optimal release profile,
an improvement in the structure of the microspheres would be nec-
essary. To do that, new combinations of polymers to form their ma-
trix or different type of coatings should be tested. Moreover, as long
Table 1. Effective diffusion coefficient, De (m
2/s), and mass transfer coefficient, h (m/s), values for 17-b-estradiol and RITC-dextran according
to Equations (3–6)
Sampling method De (m
2/s) h (m/s) R2 (%)/RSS values
b-Estradiol RITC-dextran b-Estradiol RITC-dextran b-Estradiol RITC-dextran
Batch 2.92811015 6.67161015 8.50301010 3.0350109 98.87/1.2857103 95.41/4.4388104
Semi-continuous 3.98521015 2.64091015 9.21521010 1.2050109 98.29/2.2671103 95.72/8.6032104
Figure 8. Location of the predicted Deff and h within the residual sum of squares (RSS) level curves. (A) 17-b-Estradiol, batch sampling method; (B) 17-b-estradiol,
semi-continuous sampling method; (C) RITC-dextran, batch sampling method; (D) RITC-dextran, semi-continuous sampling method
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as the hydrogel continues to be a good support for bioactive sub-
stances and presents good cell adhesion, viability and proliferation
properties, a greater contribution of the hydrogel in the mass trans-
fer process would be desirable.
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